Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
A mayor promises Ozempic for all and says there 'will be no more fat people' in his city
“Its patent will expire next year, and it will be available as a generic and I will introduce it to the entire public health ...
Daily Reporter13h
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
FiercePharma15h
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Eli Lilly's weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly's diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...
Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...
Psychology Today2d
GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use
Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...
Novo Nordisk Has Mitigation Plans to Minimize Disruption From Port Strikes, CNBC Reports
(Reuters) - Danish drugmaker Novo Nordisk has mitigation plans in place to minimize or prevent any disruption to its ...
Becker's Hospital Review3d
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Dana Filmore, a grandmother from Columbus, Ohio, is among thousands of plaintiffs filing a federal lawsuit against pharmaceutical companies Novo Nordisk and Eli Lilly, alleging Ozempic and Mounjaro ...
verywellhealth3d
Why Is Ozempic So Expensive? Novo Nordisk Blames Prescription Drug Middlemen
"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...
Opinion
The Columbian3dOpinion
Jarvis: High weight loss drug costs hurt
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...
Opinion
The Scranton Times-Tribune4dOpinion
Lisa Jarvis: Who’s really keeping Ozempic and Wegovy prices so high?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...